Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2016

01-06-2016 | Neurophthalmology

Ocular Findings of Myotonic Dystrophy Type 1 in the Korean Population

Authors: Se Hyun Choi, Hee Kyung Yang, Jeong-Min Hwang, Kyung Seok Park

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 6/2016

Login to get access

Abstract

Purpose

To investigate ocular findings in a Korean population with myotonic dystrophy type 1 (DM1).

Methods

A total of 24 Korean patients with DM1, ranging in age from 4 to 71 years, were examined over a period from June 2004 to May 2014. Ophthalmologic examinations including visual acuity assessment, slit-lamp biomicroscopy, ocular motility, cycloplegic refraction, and fundus examination were performed in all patients, and brain magnetic resonance (MR) imaging was performed in 15 patients.

Results

The ocular findings, in order of decreasing prevalence, were as follows: cataract (17 patients, 71 %), myopia (22 eyes, 59 %), hyperopia (13 eyes, 35 %), ptosis (6 patients, 25 %), epiretinal membrane (5 patients, 21 %), exotropia (4 patients, 17 %), ocular motility limitations (4 patients, 17 %), blepharitis (2 patients, 8 %), pigmentary retinopathy (2 patients, 8 %), lid lag (1 patient, 4 %), esotropia (1 patient, 4 %), and myelinated nerve fiber layer (1 patient, 4 %). Five of eight patients (63 %) with CTG repeats ≥ 700 underwent cataract extraction, as did one of 13 patients (8 %) with CTG repeats < 700 (P = 0.014). All four patients who showed limited ocular motility had CTG repeats ≥ 1000. Brain MR imaging showed periventricular white matter lesions in three patients, diffuse brain atrophy in two patients, and extraocular muscle atrophy in two patients.

Conclusions

Korean patients with DM1 showed a high incidence of exotropia in comparison to Caucasian patients with DM1. Our study suggests a possible correlation between the severity of cataract and ocular motility limitation and the size of CTG repeats.
Literature
1.
go back to reference Harper PS (1979) Myotonic dystrophy. Saunders, Philadelphia Harper PS (1979) Myotonic dystrophy. Saunders, Philadelphia
2.
go back to reference Brook JD, McCurrach ME, Harley HG et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 69:385PubMed Brook JD, McCurrach ME, Harley HG et al (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 69:385PubMed
3.
go back to reference Day JW, Ricker K, Jacobsen JF et al (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664CrossRefPubMed Day JW, Ricker K, Jacobsen JF et al (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664CrossRefPubMed
4.
go back to reference Ranum LP, Day JW (2004) Myotonic dystrophy: RNA pathogenesis comes into focus. American J Human Gen Am J Hum Genet 74:793–804CrossRef Ranum LP, Day JW (2004) Myotonic dystrophy: RNA pathogenesis comes into focus. American J Human Gen Am J Hum Genet 74:793–804CrossRef
5.
go back to reference Diamond GR (1995) Ocular manifestations of genetic and development diseases. Curr Opin Ophthalmol 6:70–76CrossRefPubMed Diamond GR (1995) Ocular manifestations of genetic and development diseases. Curr Opin Ophthalmol 6:70–76CrossRefPubMed
6.
go back to reference Bollen E, den Heyer JC, Tolsma MH et al (1992) Eye movements in myotonic dystrophy. J Neurol 115:445–450 Bollen E, den Heyer JC, Tolsma MH et al (1992) Eye movements in myotonic dystrophy. J Neurol 115:445–450
7.
go back to reference Koca MR, Horn F, Korth M (1992) Alterations of saccadic eye movements in myotonic dystrophy. Graefes Arch Clin Exp Ophthalmol 230:437–441CrossRefPubMed Koca MR, Horn F, Korth M (1992) Alterations of saccadic eye movements in myotonic dystrophy. Graefes Arch Clin Exp Ophthalmol 230:437–441CrossRefPubMed
8.
go back to reference Osanai R, Kinoshita M, Hirose K (2007) Eye movement disorders in myotonic dystrophy type 1. Acta Oto-laryngol 559:78–84CrossRef Osanai R, Kinoshita M, Hirose K (2007) Eye movement disorders in myotonic dystrophy type 1. Acta Oto-laryngol 559:78–84CrossRef
9.
go back to reference Verhagen WI, Huygen PL (1997) Abnormalities of ocular motility in myotonic dystrophy. J Neurol 120:1907–1909 Verhagen WI, Huygen PL (1997) Abnormalities of ocular motility in myotonic dystrophy. J Neurol 120:1907–1909
10.
go back to reference Anastasopoulos D, Kimmig H, Mergner T et al (1996) Abnormalities of ocular motility in myotonic dystrophy. J Neurol 119:1923–1932 Anastasopoulos D, Kimmig H, Mergner T et al (1996) Abnormalities of ocular motility in myotonic dystrophy. J Neurol 119:1923–1932
11.
go back to reference Ajroud-Driss S, Sufit R, Siddique T et al (2008) Oculomotor involvement in myotonic dystrophy type 2. Muscle Nerve 38:1326–1329CrossRefPubMed Ajroud-Driss S, Sufit R, Siddique T et al (2008) Oculomotor involvement in myotonic dystrophy type 2. Muscle Nerve 38:1326–1329CrossRefPubMed
12.
go back to reference Wong VA, Beckingsale PS, Oley CA et al (2002) Management of myogenic ptosis. Ophthalmology 109:1023–1031CrossRefPubMed Wong VA, Beckingsale PS, Oley CA et al (2002) Management of myogenic ptosis. Ophthalmology 109:1023–1031CrossRefPubMed
13.
go back to reference Kimizuka Y, Kiyosawa M, Tamai M et al (1993) Retinal changes in myotonic dystrophy Clinical and follow-up evaluation. Retina 13:129–135CrossRefPubMed Kimizuka Y, Kiyosawa M, Tamai M et al (1993) Retinal changes in myotonic dystrophy Clinical and follow-up evaluation. Retina 13:129–135CrossRefPubMed
15.
go back to reference Osanai R, Kinoshita M, Hirose K (1998) Saccadic slowing in myotonic dystrophy and CTG repeat expansion. J Neurol 245:674–680CrossRefPubMed Osanai R, Kinoshita M, Hirose K (1998) Saccadic slowing in myotonic dystrophy and CTG repeat expansion. J Neurol 245:674–680CrossRefPubMed
16.
go back to reference Isashiki Y, Nakagawa M, Yamada H et al (1994) Ocular manifestations in mitochondrial DNA abnormalities. Nippon Ganka Gakkai Zasshi 98:3–12PubMed Isashiki Y, Nakagawa M, Yamada H et al (1994) Ocular manifestations in mitochondrial DNA abnormalities. Nippon Ganka Gakkai Zasshi 98:3–12PubMed
18.
go back to reference Bollinger KE, Kattouf V, Arthur B et al (2008) Hypermetropia and esotropia in myotonic dystrophy. J AAPOS 12:69–71CrossRefPubMed Bollinger KE, Kattouf V, Arthur B et al (2008) Hypermetropia and esotropia in myotonic dystrophy. J AAPOS 12:69–71CrossRefPubMed
19.
go back to reference Jenkins RH (1992) Demographics: geographical variations in the prevalence and management of exotropia. Am Orthop J 42:82–87 Jenkins RH (1992) Demographics: geographical variations in the prevalence and management of exotropia. Am Orthop J 42:82–87
20.
go back to reference Yoon KC, Mun GH, Kim SD et al (2011) Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008–2009. Korean J Ophthalmol 25:421–433CrossRefPubMedPubMedCentral Yoon KC, Mun GH, Kim SD et al (2011) Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008–2009. Korean J Ophthalmol 25:421–433CrossRefPubMedPubMedCentral
21.
go back to reference Kim MJ, Park KH, Kim CY et al (2014) The distribution of intraocular pressure and associated systemic factors in a Korean population: The Korea National Health and Nutrition Examination Survey. Acta Ophthalmol 92:e507–513CrossRefPubMed Kim MJ, Park KH, Kim CY et al (2014) The distribution of intraocular pressure and associated systemic factors in a Korean population: The Korea National Health and Nutrition Examination Survey. Acta Ophthalmol 92:e507–513CrossRefPubMed
22.
go back to reference Raitta C, Karli P (1982) Ocular findings in myotonic dystrophy. Ann Ophthalmol 14:647–650PubMed Raitta C, Karli P (1982) Ocular findings in myotonic dystrophy. Ann Ophthalmol 14:647–650PubMed
23.
go back to reference Ginsberg J, Hamblet J, Menefee M (1978) Ocular abnormality in myotonic dystrophy. Ann Ophthalmo 10:1021–1028 Ginsberg J, Hamblet J, Menefee M (1978) Ocular abnormality in myotonic dystrophy. Ann Ophthalmo 10:1021–1028
24.
go back to reference Kim TN, Lee JE, Lee EJ et al (2014) Prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes: the 2008–2009 Korea National Health and Nutrition Examination Survey. PLoS One 9, e94189CrossRefPubMedPubMedCentral Kim TN, Lee JE, Lee EJ et al (2014) Prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes: the 2008–2009 Korea National Health and Nutrition Examination Survey. PLoS One 9, e94189CrossRefPubMedPubMedCentral
26.
go back to reference Osani R, Kinoshita M, Hirose K et al. (2007) Eye movement disorders in myotonic dystrophy type 1. Acta Otolaryngol Suppl.(559):78–84 Osani R, Kinoshita M, Hirose K et al. (2007) Eye movement disorders in myotonic dystrophy type 1. Acta Otolaryngol Suppl.(559):78–84
27.
go back to reference Marchini C, Lonigro R, Verriello L et al (2000) Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 57:74–82CrossRefPubMed Marchini C, Lonigro R, Verriello L et al (2000) Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet 57:74–82CrossRefPubMed
28.
go back to reference Romeo V, Pegoraro E, Ferrati C et al (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257:1246–1255CrossRefPubMed Romeo V, Pegoraro E, Ferrati C et al (2010) Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol 257:1246–1255CrossRefPubMed
29.
go back to reference Kersten HM, Roxburgh RH, Child N et al (2014) Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J Neurol 261:37–44CrossRefPubMed Kersten HM, Roxburgh RH, Child N et al (2014) Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J Neurol 261:37–44CrossRefPubMed
30.
go back to reference You Q, Xu L, Jonas JB (2008) Prevalence and associations of epiretinal membranes in adult Chinese: the Beijing eye study. Eye 22:874–879CrossRefPubMed You Q, Xu L, Jonas JB (2008) Prevalence and associations of epiretinal membranes in adult Chinese: the Beijing eye study. Eye 22:874–879CrossRefPubMed
31.
go back to reference Kawasaki R, Wang JJ, Mitchell P et al (2008) Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmmol 92:1320–132CrossRef Kawasaki R, Wang JJ, Mitchell P et al (2008) Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmmol 92:1320–132CrossRef
Metadata
Title
Ocular Findings of Myotonic Dystrophy Type 1 in the Korean Population
Authors
Se Hyun Choi
Hee Kyung Yang
Jeong-Min Hwang
Kyung Seok Park
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3266-5

Other articles of this Issue 6/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2016 Go to the issue